These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19383811)

  • 1. p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
    Cescon DW; Bradbury PA; Asomaning K; Hopkins J; Zhai R; Zhou W; Wang Z; Kulke M; Su L; Ma C; Xu W; Marshall AL; Heist RS; Wain JC; Lynch TJ; Christiani DC; Liu G
    Clin Cancer Res; 2009 May; 15(9):3103-9. PubMed ID: 19383811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.
    Renouf DJ; Zhai R; Sun B; Xu W; Cheung WY; Heist RS; Kulke MH; Cescon D; Asomaning K; Marshall AL; Li S; Christiani DC; Liu G
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1482-8. PubMed ID: 23735059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.
    Liu G; Cescon DW; Zhai R; Zhou W; Kulke MH; Ma C; Xu W; Su L; Asomaning K; Heist RS; Wain JC; Lynch TJ; Christiani DC
    Dis Esophagus; 2010 Jan; 23(1):36-9. PubMed ID: 19302219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
    Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
    J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).
    Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X
    Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.
    Dong J; Ren B; Hu Z; Chen J; Hu L; Dai J; Jin G; Xu L; Shen H
    Mol Carcinog; 2011 Jun; 50(6):433-8. PubMed ID: 21268124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 Arg72Pro and MDM2 SNP309 polymorphisms cooperate to increase lung adenocarcinoma risk in Chinese female non-smokers: a case control study.
    Ren YW; Yin ZH; Wan Y; Guan P; Wu W; Li XL; Zhou BS
    Asian Pac J Cancer Prev; 2013; 14(9):5415-20. PubMed ID: 24175836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Cao YY; Ge H; Chen LQ; Chen ZF; Wen DG; Li Y; Zhang JH
    Ai Zheng; 2007 Oct; 26(10):1052-7. PubMed ID: 17927872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder.
    Horikawa Y; Nadaoka J; Saito M; Kumazawa T; Inoue T; Yuasa T; Tsuchiya N; Nishiyama H; Ogawa O; Habuchi T
    Oncol Rep; 2008 Jul; 20(1):49-55. PubMed ID: 18575717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
    Han JY; Lee GK; Jang DH; Lee SY; Lee JS
    Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival.
    Toffoli G; Biason P; Russo A; De Mattia E; Cecchin E; Hattinger CM; Pasello M; Alberghini M; Ferrari C; Scotlandi K; Picci P; Serra M
    Clin Cancer Res; 2009 May; 15(10):3550-6. PubMed ID: 19451596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Xia T; Li N; Zhang J; Yang Y; Cong W; Deng Q; Lan K; Zhou W
    Protein Cell; 2013 Jan; 4(1):71-81. PubMed ID: 23292895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinoma.
    Ma J; Zhang J; Ning T; Chen Z; Xu C
    J Hum Genet; 2012 Apr; 57(4):261-4. PubMed ID: 22336889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.
    Hong Y; Miao X; Zhang X; Ding F; Luo A; Guo Y; Tan W; Liu Z; Lin D
    Cancer Res; 2005 Oct; 65(20):9582-7. PubMed ID: 16230424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.
    Yang M; Guo Y; Zhang X; Miao X; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
    Carcinogenesis; 2007 Sep; 28(9):1996-2001. PubMed ID: 17638920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
    Enokida Y; Shimizu K; Atsumi J; Kakegawa S; Takase Y; Kaira K; Yashima H; Araki T; Nakazawa S; Ohtaki Y; Nagashima T; Alexander L; Usui K; Ishikawa T; Hayashizaki Y; Takeyoshi I
    Cancer Med; 2016 Aug; 5(8):1791-801. PubMed ID: 27228500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation.
    Tu HF; Chen HW; Kao SY; Lin SC; Liu CJ; Chang KW
    Radiother Oncol; 2008 May; 87(2):243-52. PubMed ID: 18423915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.
    Li J; Tang Y; Huang L; Yu Q; Hu G; Yuan X
    PLoS One; 2016; 11(7):e0158613. PubMed ID: 27414035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
    Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
    Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
    Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.